| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 4.22e-07 | 15 | 86 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | nitrate reductase activity | 5.48e-05 | 3 | 86 | 2 | GO:0008940 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 1.82e-04 | 5 | 86 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.89e-04 | 276 | 86 | 7 | GO:0003730 | |
| GeneOntologyMolecularFunction | molybdenum ion binding | 2.72e-04 | 6 | 86 | 2 | GO:0030151 | |
| GeneOntologyMolecularFunction | molybdopterin cofactor binding | 2.72e-04 | 6 | 86 | 2 | GO:0043546 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 2.85e-04 | 134 | 86 | 5 | GO:0003697 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 6.30e-04 | 39 | 86 | 3 | GO:0000993 | |
| GeneOntologyMolecularFunction | mRNA binding | 7.90e-04 | 694 | 86 | 10 | GO:0003729 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.83e-04 | 465 | 86 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 9.60e-04 | 45 | 86 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | nitrite reductase activity | 9.83e-04 | 11 | 86 | 2 | GO:0098809 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 9.83e-04 | 11 | 86 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 1.18e-03 | 12 | 86 | 2 | GO:0050815 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.40e-03 | 112 | 86 | 4 | GO:0090079 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 1.61e-03 | 14 | 86 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | SEPTIN8 ATAD1 SMARCA4 MFN2 DHX57 RECQL GNAO1 ATP2B4 MFN1 DHX9 | 1.81e-03 | 775 | 86 | 10 | GO:0017111 |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 2.12e-03 | 16 | 86 | 2 | GO:0043138 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.22e-03 | 127 | 86 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors | 2.39e-03 | 17 | 86 | 2 | GO:0016661 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 2.78e-03 | 65 | 86 | 3 | GO:0070063 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 2.86e-03 | 439 | 86 | 7 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 2.86e-03 | 439 | 86 | 7 | GO:0019001 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 2.90e-03 | 66 | 86 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 2.90e-03 | 66 | 86 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | SEPTIN8 ATAD1 SMARCA4 MFN2 DHX57 RECQL GNAO1 ATP2B4 MFN1 DHX9 | 3.21e-03 | 839 | 86 | 10 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | SEPTIN8 ATAD1 SMARCA4 MFN2 DHX57 RECQL GNAO1 ATP2B4 MFN1 DHX9 | 3.24e-03 | 840 | 86 | 10 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | SEPTIN8 ATAD1 SMARCA4 MFN2 DHX57 RECQL GNAO1 ATP2B4 MFN1 DHX9 | 3.24e-03 | 840 | 86 | 10 | GO:0016818 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.13e-03 | 151 | 86 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 4.37e-03 | 23 | 86 | 2 | GO:0005346 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 2.98e-09 | 31 | 86 | 6 | GO:0070935 | |
| GeneOntologyBiologicalProcess | female meiosis II | 4.20e-09 | 6 | 86 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 4.20e-09 | 6 | 86 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 4.20e-09 | 6 | 86 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 3.25e-08 | 77 | 86 | 7 | GO:0048255 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 7.63e-08 | 87 | 86 | 7 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 8.26e-08 | 88 | 86 | 7 | GO:0043489 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 2.14e-07 | 101 | 86 | 7 | GO:1902369 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 2.24e-07 | 151 | 86 | 8 | GO:0045727 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 5.20e-07 | 115 | 86 | 7 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 3.93e-06 | 26 | 86 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 6.18e-06 | 29 | 86 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 9.99e-06 | 118 | 86 | 6 | GO:2000243 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 1.67e-05 | 37 | 86 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 1.72e-05 | 2 | 86 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 1.72e-05 | 2 | 86 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 3.68e-05 | 45 | 86 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | regulation of translation | 3.94e-05 | 494 | 86 | 10 | GO:0006417 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 4.38e-05 | 47 | 86 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 4.46e-05 | 309 | 86 | 8 | GO:0061013 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 5.14e-05 | 3 | 86 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 5.14e-05 | 3 | 86 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 5.14e-05 | 3 | 86 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 6.13e-05 | 418 | 86 | 9 | GO:0009895 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 6.55e-05 | 52 | 86 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | viral gene expression | 9.31e-05 | 109 | 86 | 5 | GO:0019080 | |
| GeneOntologyBiologicalProcess | viral transcription | 1.01e-04 | 58 | 86 | 4 | GO:0019083 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 1.03e-04 | 4 | 86 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | nitrate metabolic process | 1.03e-04 | 4 | 86 | 2 | GO:0042126 | |
| GeneOntologyBiologicalProcess | cell maturation | 1.27e-04 | 267 | 86 | 7 | GO:0048469 | |
| GeneOntologyBiologicalProcess | translation | PASK MRPL16 PARP16 DAZ4 ELAVL1 DAZ1 RPS21 RBM8A DAZ3 DAZ2 EP300 DHX9 | 1.54e-04 | 824 | 86 | 12 | GO:0006412 |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 1.65e-04 | 373 | 86 | 8 | GO:0006402 | |
| GeneOntologyBiologicalProcess | cellular detoxification of nitrogen compound | 1.70e-04 | 5 | 86 | 2 | GO:0070458 | |
| GeneOntologyBiologicalProcess | detoxification of nitrogen compound | 1.70e-04 | 5 | 86 | 2 | GO:0051410 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 2.19e-04 | 292 | 86 | 7 | GO:0043488 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | FANCC SOX11 CRYGB FLT1 IL18 ADAMTS9 PSG5 SEC24B SMARCA4 MFN2 LAMB3 KDM2A EP300 JHY WDR48 | 2.21e-04 | 1269 | 86 | 15 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 2.55e-04 | 6 | 86 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 2.73e-04 | 75 | 86 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 3.03e-04 | 308 | 86 | 7 | GO:0043487 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription termination | 3.81e-04 | 34 | 86 | 3 | GO:0006353 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 3.85e-04 | 82 | 86 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 4.42e-04 | 432 | 86 | 8 | GO:0006401 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial fission | 4.73e-04 | 8 | 86 | 2 | GO:0090258 | |
| GeneOntologyBiologicalProcess | oogenesis | 4.94e-04 | 156 | 86 | 5 | GO:0048477 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 5.04e-04 | 240 | 86 | 6 | GO:0140013 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 5.22e-04 | 443 | 86 | 8 | GO:1903311 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 5.71e-04 | 91 | 86 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 6.30e-04 | 696 | 86 | 10 | GO:0034655 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 6.38e-04 | 251 | 86 | 6 | GO:2000241 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 6.95e-04 | 354 | 86 | 7 | GO:0071695 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 7.07e-04 | 464 | 86 | 8 | GO:0141188 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 7.48e-04 | 171 | 86 | 5 | GO:0048593 | |
| GeneOntologyBiologicalProcess | oocyte development | 7.84e-04 | 99 | 86 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 8.15e-04 | 100 | 86 | 4 | GO:0043242 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 8.19e-04 | 44 | 86 | 3 | GO:0001736 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | SOX11 PASK TARDBP IL18 DAZ4 SMARCA4 MFN2 ELAVL1 KDM2A DAZ1 PANX1 DAZ3 DAZ2 EP300 DHX9 | 8.73e-04 | 1446 | 86 | 15 | GO:0010628 |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 8.75e-04 | 45 | 86 | 3 | GO:0007164 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 8.97e-04 | 268 | 86 | 6 | GO:1903046 | |
| GeneOntologyBiologicalProcess | lens development in camera-type eye | 9.10e-04 | 103 | 86 | 4 | GO:0002088 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 9.10e-04 | 103 | 86 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | intracellular distribution of mitochondria | 1.10e-03 | 12 | 86 | 2 | GO:0048312 | |
| GeneOntologyCellularComponent | perichromatin fibrils | 3.84e-06 | 8 | 87 | 3 | GO:0005726 | |
| MousePheno | absent ovarian follicles | 6.59e-06 | 51 | 73 | 5 | MP:0002777 | |
| Domain | RRM_1 | 5.01e-08 | 208 | 88 | 10 | PF00076 | |
| Domain | RRM | 7.46e-08 | 217 | 88 | 10 | SM00360 | |
| Domain | RRM_dom | 1.14e-07 | 227 | 88 | 10 | IPR000504 | |
| Domain | RRM | 1.29e-07 | 230 | 88 | 10 | PS50102 | |
| Domain | - | 2.23e-07 | 244 | 88 | 10 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 3.73e-07 | 258 | 88 | 10 | IPR012677 | |
| Domain | Bromodomain_CS | 6.35e-06 | 26 | 88 | 4 | IPR018359 | |
| Domain | Mitofusin_fam | 2.19e-05 | 2 | 88 | 2 | IPR027094 | |
| Domain | Fzo_mitofusin | 2.19e-05 | 2 | 88 | 2 | PF04799 | |
| Domain | Fzo/mitofusin_HR2 | 2.19e-05 | 2 | 88 | 2 | IPR006884 | |
| Domain | BROMODOMAIN_1 | 2.70e-05 | 37 | 88 | 4 | PS00633 | |
| Domain | Bromodomain | 3.00e-05 | 38 | 88 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.08e-05 | 41 | 88 | 4 | PS50014 | |
| Domain | BROMO | 4.49e-05 | 42 | 88 | 4 | SM00297 | |
| Domain | Bromodomain | 4.49e-05 | 42 | 88 | 4 | IPR001487 | |
| Domain | - | 4.49e-05 | 42 | 88 | 4 | 1.20.920.10 | |
| Domain | MOSC | 6.56e-05 | 3 | 88 | 2 | PS51340 | |
| Domain | MOSC | 6.56e-05 | 3 | 88 | 2 | PF03473 | |
| Domain | MOSC_N | 6.56e-05 | 3 | 88 | 2 | PF03476 | |
| Domain | MOSC_N | 6.56e-05 | 3 | 88 | 2 | IPR005303 | |
| Domain | MoCF_Sase_C | 6.56e-05 | 3 | 88 | 2 | IPR005302 | |
| Domain | DDT | 1.31e-04 | 4 | 88 | 2 | PF02791 | |
| Domain | DDT | 2.17e-04 | 5 | 88 | 2 | SM00571 | |
| Domain | WSD | 2.17e-04 | 5 | 88 | 2 | PF15613 | |
| Domain | WHIM1 | 2.17e-04 | 5 | 88 | 2 | PF15612 | |
| Domain | DDT_dom | 2.17e-04 | 5 | 88 | 2 | IPR018501 | |
| Domain | Pyrv_Knase-like_insert_dom | 2.17e-04 | 5 | 88 | 2 | IPR011037 | |
| Domain | WHIM1_dom | 2.17e-04 | 5 | 88 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 2.17e-04 | 5 | 88 | 2 | IPR028941 | |
| Domain | DDT | 3.25e-04 | 6 | 88 | 2 | PS50827 | |
| Domain | RNA_pol_II-bd | 4.54e-04 | 7 | 88 | 2 | IPR006903 | |
| Domain | CTD_bind | 4.54e-04 | 7 | 88 | 2 | PF04818 | |
| Domain | CNMP_BINDING_1 | 4.54e-04 | 32 | 88 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 4.54e-04 | 32 | 88 | 3 | PS00889 | |
| Domain | cNMP | 5.44e-04 | 34 | 88 | 3 | SM00100 | |
| Domain | cNMP_binding | 5.44e-04 | 34 | 88 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 5.93e-04 | 35 | 88 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 5.93e-04 | 35 | 88 | 3 | PS50042 | |
| Domain | RPR | 6.03e-04 | 8 | 88 | 2 | SM00582 | |
| Domain | CID | 6.03e-04 | 8 | 88 | 2 | PS51391 | |
| Domain | CID_dom | 6.03e-04 | 8 | 88 | 2 | IPR006569 | |
| Domain | cNMP-bd-like | 7.57e-04 | 38 | 88 | 3 | IPR018490 | |
| Domain | PAS_9 | 9.64e-04 | 10 | 88 | 2 | PF13426 | |
| Domain | Hud_Sxl_RNA | 9.64e-04 | 10 | 88 | 2 | IPR002343 | |
| Domain | PTBI | 1.17e-03 | 11 | 88 | 2 | SM00310 | |
| Domain | EGF_3 | 1.40e-03 | 12 | 88 | 2 | PF12947 | |
| Domain | EGF_dom | 1.40e-03 | 12 | 88 | 2 | IPR024731 | |
| Domain | IRS_PTB | 1.40e-03 | 12 | 88 | 2 | PS51064 | |
| Domain | - | 1.50e-03 | 48 | 88 | 3 | 2.60.120.10 | |
| Domain | Helicase_C | 1.64e-03 | 107 | 88 | 4 | PF00271 | |
| Domain | HELICc | 1.64e-03 | 107 | 88 | 4 | SM00490 | |
| Domain | Helicase_C | 1.70e-03 | 108 | 88 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.76e-03 | 109 | 88 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.76e-03 | 109 | 88 | 4 | PS51192 | |
| Domain | DEXDc | 1.76e-03 | 109 | 88 | 4 | SM00487 | |
| Domain | RmlC-like_jellyroll | 1.79e-03 | 51 | 88 | 3 | IPR014710 | |
| Domain | Helicase_ATP-bd | 1.82e-03 | 110 | 88 | 4 | IPR014001 | |
| Domain | Gelsolin | 1.93e-03 | 14 | 88 | 2 | PF00626 | |
| Domain | IRS_PTB | 1.93e-03 | 14 | 88 | 2 | IPR002404 | |
| Domain | MORN | 1.93e-03 | 14 | 88 | 2 | SM00698 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.93e-03 | 14 | 88 | 2 | IPR003938 | |
| Domain | G_DYNAMIN_dom | 1.93e-03 | 14 | 88 | 2 | IPR030381 | |
| Domain | Gelsolin-like_dom | 1.93e-03 | 14 | 88 | 2 | IPR007123 | |
| Domain | IRS | 1.93e-03 | 14 | 88 | 2 | PF02174 | |
| Domain | G_DYNAMIN_2 | 1.93e-03 | 14 | 88 | 2 | PS51718 | |
| Domain | Ion_trans_dom | 2.07e-03 | 114 | 88 | 4 | IPR005821 | |
| Domain | Ion_trans | 2.07e-03 | 114 | 88 | 4 | PF00520 | |
| Domain | MORN | 2.21e-03 | 15 | 88 | 2 | IPR003409 | |
| Domain | Dynamin_GTPase | 2.21e-03 | 15 | 88 | 2 | IPR001401 | |
| Domain | Dynamin_N | 2.21e-03 | 15 | 88 | 2 | PF00350 | |
| Domain | MORN | 2.21e-03 | 15 | 88 | 2 | PF02493 | |
| Domain | Dynamin_SF | 2.21e-03 | 15 | 88 | 2 | IPR022812 | |
| Domain | DUF1605 | 2.85e-03 | 17 | 88 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 2.85e-03 | 17 | 88 | 2 | PF07717 | |
| Domain | HA2 | 3.20e-03 | 18 | 88 | 2 | SM00847 | |
| Domain | HA2 | 3.20e-03 | 18 | 88 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 3.20e-03 | 18 | 88 | 2 | IPR007502 | |
| Domain | Zinc_finger_PHD-type_CS | 3.58e-03 | 65 | 88 | 3 | IPR019786 | |
| Domain | SRCR | 4.35e-03 | 21 | 88 | 2 | PF00530 | |
| Pathway | WP_MALE_INFERTILITY | 9.74e-06 | 145 | 73 | 7 | M39856 | |
| Pathway | WP_OVARIAN_INFERTILITY | 3.07e-05 | 35 | 73 | 4 | MM15948 | |
| Pathway | WP_MRNA_PROCESSING | 1.04e-04 | 451 | 73 | 10 | MM15946 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.59e-04 | 301 | 73 | 8 | MM15983 | |
| Pubmed | 5.14e-12 | 8 | 88 | 5 | 10951504 | ||
| Pubmed | 3.83e-11 | 4 | 88 | 4 | 7670487 | ||
| Pubmed | 3.83e-11 | 4 | 88 | 4 | 11694340 | ||
| Pubmed | 3.83e-11 | 4 | 88 | 4 | 9321470 | ||
| Pubmed | 3.83e-11 | 4 | 88 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 3.83e-11 | 4 | 88 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 3.83e-11 | 4 | 88 | 4 | 11688365 | |
| Pubmed | 3.83e-11 | 4 | 88 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 3.83e-11 | 4 | 88 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 3.83e-11 | 4 | 88 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 3.83e-11 | 4 | 88 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 3.83e-11 | 4 | 88 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 3.83e-11 | 4 | 88 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 3.83e-11 | 4 | 88 | 4 | 16963411 | |
| Pubmed | Eif4enif1 haploinsufficiency disrupts oocyte mitochondrial dynamics and leads to subfertility. | 7.22e-11 | 12 | 88 | 5 | 38088064 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 23579190 | ||
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 1.91e-10 | 5 | 88 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 1.91e-10 | 5 | 88 | 4 | 17416365 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 22293198 | ||
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 1.91e-10 | 5 | 88 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 1.91e-10 | 5 | 88 | 4 | 8968756 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 1.91e-10 | 5 | 88 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 1.91e-10 | 5 | 88 | 4 | 26411291 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 1.91e-10 | 5 | 88 | 4 | 14648873 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 8896558 | ||
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 1.91e-10 | 5 | 88 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 1.91e-10 | 5 | 88 | 4 | 9288969 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 1.91e-10 | 5 | 88 | 4 | 10903443 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 1.91e-10 | 5 | 88 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 1.91e-10 | 5 | 88 | 4 | 8845845 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 1.91e-10 | 5 | 88 | 4 | 19783541 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 17761180 | ||
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 1.91e-10 | 5 | 88 | 4 | 12200456 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 11514340 | ||
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 1.91e-10 | 5 | 88 | 4 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 1.91e-10 | 5 | 88 | 4 | 23223451 | |
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 11804965 | ||
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 21270429 | ||
| Pubmed | 1.91e-10 | 5 | 88 | 4 | 8661148 | ||
| Pubmed | 5.58e-10 | 17 | 88 | 5 | 12360237 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 5.72e-10 | 6 | 88 | 4 | 18452650 | |
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 5.72e-10 | 6 | 88 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 5.72e-10 | 6 | 88 | 4 | 31355046 | |
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 20157580 | ||
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 5.72e-10 | 6 | 88 | 4 | 26077710 | |
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 17526644 | ||
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 5.72e-10 | 6 | 88 | 4 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 5.72e-10 | 6 | 88 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 5.72e-10 | 6 | 88 | 4 | 23417416 | |
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 32170089 | ||
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 16278232 | ||
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 5.72e-10 | 6 | 88 | 4 | 16001084 | |
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 5.72e-10 | 6 | 88 | 4 | 1869307 | |
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 11390979 | ||
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 27632217 | ||
| Pubmed | 1.05e-09 | 19 | 88 | 5 | 28380054 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 15081113 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 22699423 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 1.33e-09 | 7 | 88 | 4 | 16946704 | |
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 10857750 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 1.33e-09 | 7 | 88 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 1.33e-09 | 7 | 88 | 4 | 26826184 | |
| Pubmed | TARDBP SCAF8 DAZ4 RBMS1 ELAVL1 DAZ1 RBM8A DAZ3 DAZ2 SCAF4 DHX9 | 1.34e-09 | 347 | 88 | 11 | 16033648 | |
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 2.66e-09 | 8 | 88 | 4 | 23204224 | |
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 29883445 | ||
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 10823932 | ||
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 11869379 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 2.66e-09 | 8 | 88 | 4 | 32339196 | |
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 33749946 | ||
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 22621333 | ||
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 32686646 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 4.77e-09 | 9 | 88 | 4 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 4.77e-09 | 9 | 88 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 4.77e-09 | 9 | 88 | 4 | 19695304 | |
| Pubmed | 4.77e-09 | 9 | 88 | 4 | 28235998 | ||
| Pubmed | 4.77e-09 | 9 | 88 | 4 | 20159962 | ||
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 7.94e-09 | 10 | 88 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 7.94e-09 | 10 | 88 | 4 | 38433229 | |
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 23810942 | ||
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 12837688 | ||
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 10601091 | ||
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 9922113 | ||
| Cytoband | Yq11.223 | 3.23e-05 | 93 | 88 | 4 | Yq11.223 | |
| Cytoband | 20q13.3 | 6.75e-04 | 20 | 88 | 2 | 20q13.3 | |
| GeneFamily | RNA binding motif containing | 2.63e-09 | 213 | 62 | 10 | 725 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.06e-04 | 27 | 62 | 3 | 1253 | |
| GeneFamily | DEAH-box helicases | 1.35e-03 | 16 | 62 | 2 | 500 | |
| GeneFamily | PHD finger proteins | 3.65e-03 | 90 | 62 | 3 | 88 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 5.75e-08 | 12 | 88 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 5.75e-08 | 12 | 88 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 1.00e-06 | 23 | 88 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 3.48e-06 | 31 | 88 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 4.51e-06 | 33 | 88 | 4 | MM701 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 178 | 88 | 6 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 178 | 88 | 6 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 179 | 88 | 6 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 1.71e-06 | 183 | 88 | 6 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.94e-06 | 187 | 88 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 160 | 88 | 5 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 173 | 88 | 5 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 176 | 88 | 5 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 2.83e-05 | 179 | 88 | 5 | 9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|COVID-19_Convalescent / Disease condition and Cell class | 2.83e-05 | 179 | 88 | 5 | 366e4a31db9e80fd1770ac9f1ae148fefeb9f7df | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 179 | 88 | 5 | 27ad6a609fe1f7532b142d0147bccf918704a6dd | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-05 | 184 | 88 | 5 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-05 | 184 | 88 | 5 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-05 | 185 | 88 | 5 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 186 | 88 | 5 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 186 | 88 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.95e-05 | 192 | 88 | 5 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 193 | 88 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 193 | 88 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 193 | 88 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| Drug | boron trichloride | 3.11e-09 | 6 | 88 | 4 | CID000025135 | |
| Drug | Vistar | 2.64e-07 | 36 | 88 | 5 | CID000040896 | |
| Drug | desmethylazelastine | 3.66e-07 | 16 | 88 | 4 | CID000162558 | |
| Drug | propham | 7.41e-07 | 44 | 88 | 5 | CID000024685 | |
| Drug | dazmegrel | 7.72e-07 | 19 | 88 | 4 | CID000053555 | |
| Drug | YM 026 | 7.72e-07 | 19 | 88 | 4 | CID000004443 | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; HL60; HG-U133A | 9.69e-07 | 197 | 88 | 8 | 1746_DN | |
| Drug | AZFd | 1.74e-06 | 23 | 88 | 4 | CID000196489 | |
| Drug | dansylaziridine | 1.74e-06 | 23 | 88 | 4 | CID000104008 | |
| Drug | bipy | 2.09e-06 | 97 | 88 | 6 | CID000001474 | |
| Drug | d-gluconhydroximo-1,5-lactam | 6.05e-06 | 31 | 88 | 4 | CID000003479 | |
| Drug | 3-bromo-7-nitroindazole | 1.12e-05 | 36 | 88 | 4 | CID000001649 | |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.18e-05 | 198 | 88 | 7 | 7216_DN | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.18e-05 | 198 | 88 | 7 | 1688_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.22e-05 | 199 | 88 | 7 | 3280_UP | |
| Drug | 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1.48e-05 | 2 | 88 | 2 | ctd:D012856 | |
| Drug | molybdenum disulfide | 2.29e-05 | 43 | 88 | 4 | CID000014823 | |
| Drug | 2-chlorodideoxyadenosine | 2.29e-05 | 43 | 88 | 4 | CID000072194 | |
| Drug | ridogrel | 4.90e-05 | 52 | 88 | 4 | CID005362391 | |
| Drug | azafagomine | 7.04e-05 | 57 | 88 | 4 | CID011957435 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 7.80e-05 | 183 | 88 | 6 | 7498_DN | |
| Drug | N(4)-hydroxycytosine | 8.82e-05 | 4 | 88 | 2 | ctd:C021202 | |
| Drug | N(4)-hydroxycytidine | 8.82e-05 | 4 | 88 | 2 | ctd:C010737 | |
| Drug | NSC56408 | 9.79e-05 | 62 | 88 | 4 | CID000005604 | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A | 1.04e-04 | 193 | 88 | 6 | 1412_DN | |
| Drug | Etodolac [41340-25-4]; Down 200; 14uM; PC3; HT_HG-U133A | 1.07e-04 | 194 | 88 | 6 | 2091_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.11e-04 | 195 | 88 | 6 | 999_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 6176_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 3663_DN | |
| Drug | Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HG-U133A | 1.11e-04 | 195 | 88 | 6 | 1410_UP | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HT_HG-U133A | 1.14e-04 | 196 | 88 | 6 | 4645_DN | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 6275_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 6930_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; HL60; HG-U133A | 1.17e-04 | 197 | 88 | 6 | 1602_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; HL60; HG-U133A | 1.20e-04 | 198 | 88 | 6 | 1579_UP | |
| Drug | Minoxidil [38304-91-5]; Up 200; 19.2uM; HL60; HG-U133A | 1.24e-04 | 199 | 88 | 6 | 1996_UP | |
| Drug | (+/-)-thalidomide; Up 200; 100uM; MCF7; HG-U133A | 1.24e-04 | 199 | 88 | 6 | 606_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 2769_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 2287_DN | |
| Drug | kt S | 1.25e-04 | 66 | 88 | 4 | CID006399216 | |
| Disease | Male sterility due to Y-chromosome deletions | 4.67e-09 | 8 | 86 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 4.67e-09 | 8 | 86 | 4 | C1507149 | |
| Disease | Charcot-Marie-Tooth disease type 2A2A (implicated_via_orthology) | 8.40e-06 | 2 | 86 | 2 | DOID:0110155 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 2A2B (implicated_via_orthology) | 8.40e-06 | 2 | 86 | 2 | DOID:0111557 (implicated_via_orthology) | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.30e-05 | 16 | 86 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.30e-05 | 16 | 86 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.30e-05 | 16 | 86 | 3 | 415000 | |
| Disease | Charcot-Marie-Tooth disease type 2 (implicated_via_orthology) | 5.02e-05 | 4 | 86 | 2 | DOID:0050539 (implicated_via_orthology) | |
| Disease | L lactate dehydrogenase measurement | 5.92e-05 | 26 | 86 | 3 | EFO_0004808 | |
| Disease | Amphetamine-Related Disorders | 6.98e-05 | 75 | 86 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 6.98e-05 | 75 | 86 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 6.98e-05 | 75 | 86 | 4 | C0236804 | |
| Disease | preeclampsia, fetal genotype effect measurement | 8.35e-05 | 5 | 86 | 2 | EFO_0000668, EFO_0007959 | |
| Disease | Colorectal Carcinoma | 2.09e-04 | 702 | 86 | 9 | C0009402 | |
| Disease | primary pulmonary hypertension (is_marker_for) | 2.32e-04 | 8 | 86 | 2 | DOID:14557 (is_marker_for) | |
| Disease | response to bupropion | 2.98e-04 | 9 | 86 | 2 | EFO_0006326 | |
| Disease | C-C motif chemokine 25 measurement | 2.98e-04 | 9 | 86 | 2 | EFO_0008050 | |
| Disease | Antithrombotic agent use measurement | 5.62e-04 | 55 | 86 | 3 | EFO_0009925 | |
| Disease | Coffin-Siris syndrome | 6.41e-04 | 13 | 86 | 2 | C0265338 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 6.41e-04 | 13 | 86 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Kawasaki disease (is_marker_for) | 7.47e-04 | 14 | 86 | 2 | DOID:13378 (is_marker_for) | |
| Disease | trimethylamine-N-oxide measurement | 7.47e-04 | 14 | 86 | 2 | EFO_0010541 | |
| Disease | Bladder Neoplasm | 7.63e-04 | 140 | 86 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 7.83e-04 | 141 | 86 | 4 | C0005684 | |
| Disease | melanoma | 8.06e-04 | 248 | 86 | 5 | C0025202 | |
| Disease | Alzheimer's disease (is_marker_for) | 9.45e-04 | 257 | 86 | 5 | DOID:10652 (is_marker_for) | |
| Disease | syndrome (implicated_via_orthology) | 1.25e-03 | 18 | 86 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | factor VIII measurement, Ischemic stroke | 1.39e-03 | 19 | 86 | 2 | EFO_0004630, HP_0002140 | |
| Disease | susceptibility to scarlet fever measurement | 1.61e-03 | 79 | 86 | 3 | EFO_0008409 | |
| Disease | Cardiomegaly | 1.79e-03 | 82 | 86 | 3 | C0018800 | |
| Disease | Cardiac Hypertrophy | 1.79e-03 | 82 | 86 | 3 | C1383860 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.22e-03 | 24 | 86 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | metabolic syndrome | 2.82e-03 | 200 | 86 | 4 | EFO_0000195 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MELRCGGLLFSSRFD | 1 | Q8NDL9 | |
| CDLMDGRDAFLTLAR | 1621 | Q09472 | |
| EETGEMFRVANCRGD | 101 | Q9BZ19 | |
| ICSDASDMELRLVGG | 681 | Q9NR16 | |
| ARGFARMTGVTCDDV | 856 | Q75N90 | |
| YTLREDGAMCRDVDE | 2196 | Q75N90 | |
| GYTAEGRDVDECRML | 2356 | Q75N90 | |
| SRAMDFEGKLGCDSE | 1396 | Q12830 | |
| GIDARMDETEIGSCF | 46 | Q13117 | |
| GIDARMDETEIGSCF | 46 | Q9NR90 | |
| ESREGDFGCTVMELR | 16 | P23634 | |
| RGGFDATDDACMELR | 576 | Q9NRL2 | |
| AFSGCLDLLEADMRR | 81 | Q6ZS82 | |
| GSEEGSRARMREDYD | 41 | Q9Y5S9 | |
| RGVGFARMESTEKCE | 181 | P29558 | |
| EGSDARIRCGAFMSK | 1641 | Q14571 | |
| DLTGFSRAEVMQRGC | 51 | Q9ULD8 | |
| DGMGRNLADRCTDEV | 451 | Q8IWA4 | |
| ESRGERHEGREGMTC | 961 | O75808 | |
| MEDGGLTAFEEDQRC | 1 | Q96RG2 | |
| YLGAECRTVREEMGD | 571 | Q13045 | |
| EAECTAMGLRSGNLR | 76 | Q5VT66 | |
| CHSEFDDRIRGNGME | 56 | Q6NUN7 | |
| GGAEFTTACDFRLMT | 161 | Q9NTX5 | |
| DGFSMLLRACRESEL | 651 | Q6ZRQ5 | |
| RSMGVLSDSEARCGD | 576 | Q5VYM1 | |
| AEGCSLDGLAREEMD | 1551 | Q5SYE7 | |
| GVVCRRASQEDMGLD | 2111 | A6NKB5 | |
| ASMEFLRQEDTPGCR | 761 | O43526 | |
| RISICTEFMDGGSLD | 236 | Q13163 | |
| NFMCERLGETRSRGS | 241 | P17858 | |
| MCETGEGLFIFQTRD | 201 | Q9P104 | |
| EDHMAEDCRGDIGRT | 6 | Q15717 | |
| AAKSARDLDMRDGAC | 156 | Q96RD7 | |
| EEGLGRNMSDRCSTA | 471 | O95140 | |
| RDRDSGDNGKMVCSI | 371 | Q9Y5F1 | |
| EAAGRDMLAADLRCS | 11 | Q8N5Y8 | |
| FRLRFESSMEECGGD | 2441 | O60494 | |
| FGEDRLNDRMCDPET | 1081 | Q9P2N4 | |
| GTMRRRYEDDGISDD | 16 | Q9Y2K7 | |
| ECLSMGAAADRRADS | 441 | Q9UHR4 | |
| GIDARMDETEIGSCF | 46 | Q9NQZ3 | |
| GIDARMDETEIGSCF | 211 | Q9NQZ3 | |
| GIDARMDETEIGSCF | 376 | Q9NQZ3 | |
| MCDTGEGLFTFQTRE | 201 | Q6PKX4 | |
| GIGSDERFRQCLMSD | 1016 | Q8TF40 | |
| AVLRMCDGDVGASLE | 201 | Q6P158 | |
| DRDSCSVREGMAFED | 146 | P78396 | |
| EMFRCALLETDGALE | 296 | Q00597 | |
| EGGRTALHMACERED | 656 | Q9P2S6 | |
| RDELRGQMSELTDDC | 96 | P07316 | |
| ESMASLGCFRDRERL | 321 | Q8TDC3 | |
| AECTAMGLRSGNLRD | 76 | Q969Z3 | |
| LGSRRDMPCDEESGR | 436 | Q13751 | |
| EACSTERERMGLLAD | 326 | A4GXA9 | |
| GIDARMDETEIGSCF | 46 | Q86SG3 | |
| GIDARMDETEIGSCF | 211 | Q86SG3 | |
| GERQGAICDSEMRSC | 221 | Q6ZVF9 | |
| RMFGEALEDLESCGQ | 871 | Q9C0E4 | |
| GNRPLFEDMTDSDCR | 61 | Q14116 | |
| EKLTREGAFLMDCGS | 1151 | O95487 | |
| ELESFCEGGMLDSDT | 611 | O95104 | |
| DRDDRDFDFCREMNG | 1161 | Q9UPN6 | |
| EDEALMLRDGRFACA | 31 | Q9BWG6 | |
| DGDVVCRMLGFRGVE | 426 | Q6ZMJ2 | |
| DDARMGGEEAEIRFC | 926 | Q08211 | |
| MRGSCERSGEDEEQK | 1 | Q6ZQY2 | |
| AGRLVVEMGGRCEFE | 156 | Q9NX20 | |
| REALDTEEGEFMACS | 16 | P35716 | |
| CGAIRRMGESDDSIL | 56 | P63220 | |
| GRCTEDMTEDELREF | 196 | Q13148 | |
| MGCTLSAEERAALER | 1 | P09471 | |
| RLTCEEEEEKMFGRG | 1356 | P51532 | |
| DGGLRFGEMERDCQI | 1081 | P30876 | |
| MDGTETRQRRLDSCG | 1 | Q96GZ6 | |
| RSGLRMCDLVSDFDG | 176 | P30520 | |
| MLRNCGSFTREEADE | 1036 | P53396 | |
| TDGFSGSDLKEMCRD | 291 | Q8NBU5 | |
| EIRRMENGACSSFSE | 26 | P29973 | |
| ESGRAGRDDMKADCI | 401 | P46063 | |
| FRLLCRDSGGETESM | 526 | Q8TAF3 | |
| IEARADRFSSCIDMG | 1956 | O15020 | |
| DRGRCETSASELERM | 216 | P41440 | |
| IVRCEAGEGECRTFM | 146 | Q9BSE2 | |
| MEDERSFSDICGGRL | 1 | Q14442 | |
| RRCKLEEMGFQDSDG | 301 | Q92599 | |
| FSCSRTRAGELMVGE | 1826 | Q9NY15 | |
| RGSRDMFTEFCTTGD | 931 | Q5TAH2 | |
| TEMRVCGGNEFERCS | 41 | Q6ZN57 | |
| TARTGEDVEMACSFR | 51 | Q96N03 | |
| PGVQMDEDFCSRLRE | 1101 | P17948 | |
| ECEIRDRDGGMRSDP | 216 | Q15238 | |
| DCTFDHMGRGREEAI | 191 | Q9H8U3 | |
| QMLLEGRAGDCARSS | 516 | Q8WXH2 |